ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2024

Core Points - ImmuCell Corporation is set to report unaudited financial results for the quarter and year ended December 31, 2024, after market close on February 25, 2025 [1] - A conference call to discuss these results is scheduled for February 26, 2025, at 9:00 AM ET [2] - The company anticipates no changes to the preliminary sales results disclosed on January 9, 2025 [3] - An updated Corporate Presentation slide deck will be available after market close on February 25, 2025, providing an overview of the company's business [4] - ImmuCell focuses on developing products that enhance the health and productivity of dairy and beef cattle, including First Defense and the novel treatment Re-Tain [5]